OpGen Highlights Capabilities of its Acuitas® Technologies to Rapidly Predict Antibiotic Susceptibility Using Drug Resistance Gene Profiles at ECCMID
OpGen, Inc. (OPGN)
Last opgen, inc. earnings: 11/6 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.opgen.com
Company Research
Source: GlobeNewswire
GAITHERSBURG, Md., April 25, 2017 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today announced that it has presented preliminary results supporting its Acuitas Rapid Test in development to detect antibiotic resistant genes and the use of predictive algorithms from its Acuitas Lighthouse® Knowledgebase to predict antibiotic susceptibility. The results were presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Vienna, Austria. The poster, titled “Prediction of antibiotic resistance in Escherichia coli from resistance genes,” compared phenotypic antibiotic susceptibility testing (AST) with the emerging capabilities of Lighthouse Knowledgebase informatics to predict antibiotic resistance using resistance genes from bacterial isolates. The results of testing over 1,900 E. coli isolates with PCR yielded strong prediction of phenotypic antibiotic resistance for seventeen antibiotics representing seven antibiotic classes with accuracies ran
Show less
Read more
Impact Snapshot
Event Time:
OPGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OPGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OPGN alerts
High impacting OpGen, Inc. news events
Weekly update
A roundup of the hottest topics
OPGN
News
- OpGen Provides Update on Business Operations and Strategic Opportunities [Yahoo! Finance]Yahoo! Finance
- OpGen Provides Update on Business Operations and Strategic OpportunitiesGlobeNewswire
- OpGen Receives Nasdaq Notice Regarding Delayed Form 10-K [Yahoo! Finance]Yahoo! Finance
- OpGen Receives Nasdaq Notice Regarding Delayed Form 10-KGlobeNewswire
- OpGen, Inc. (NASDAQ: OPGN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
OPGN
Earnings
- 11/14/23 - Miss
OPGN
Sec Filings
- 4/29/24 - Form 8-K
- 4/26/24 - Form DEF
- 4/25/24 - Form SC
- OPGN's page on the SEC website